MAIA Biotechnology, Inc.'s market cap is currently ―. The company's EPS TTM is $-1.341; its P/E ratio is ―; MAIA Biotechnology, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Operating Income	$ -20.18M	$ -16.18M	$ -7.79M	$ -6.98M	$ -6.92M
EBITDA	$ -20.18M	$ -16.18M	$ 0.00	$ 0.00	$ 242.00
Net Income	$ -19.77M	$ -15.81M	$ -13.29M	$ -6.67M	$ -6.49M
Balance Sheet
Cash & Short-Term Investments	$ 7.15M	$ 10.95M	$ 10.57M	$ 663.46K	$ 1.71M
Total Assets	$ 7.57M	$ 12.02M	$ 11.33M	$ 746.50K	$ 1.73M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 463.75K	$ 35.17K
Net Debt	$ -7.15M	$ -10.95M	$ -10.57M	$ -199.70K	$ -1.67M
Total Liabilities	$ 7.09M	$ 3.51M	$ 2.15M	$ 2.36M	$ 409.74K
Stockholders' Equity	$ 477.51K	$ 8.51M	$ 9.18M	$ -3.34M	$ -172.87K
Cash Flow
Free Cash Flow	$ -13.07M	$ -11.66M	$ -4.12M	$ -1.84M	$ -1.57M
Operating Cash Flow	$ -13.07M	$ -11.66M	$ -4.12M	$ -1.84M	$ -1.57M
Investing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 187.56K
Financing Cash Flow	$ 9.27M	$ 12.48M	$ 14.03M	$ 798.05K	$ 2.22M

Currency in USD

MAIA Biotechnology, Inc. Earnings and Revenue History

Income Statement >

MAIA Biotechnology, Inc. Debt to Assets

Balance Sheet >

MAIA Biotechnology, Inc. Cash Flow

Cash Flow >

MAIA Biotechnology, Inc. Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing